EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rectal budesonide: A potential game changer after Kasai hepatoportoenterostomy

Stefanie Langreen iD, Nathalie Pauer, Eva D Pfister, Norman Junge, Ulrich Baumann, Omid Madadi-Sanjani, Claus Petersen, Jens Dingemann, Nagoud Schukfeh

Journal of Pediatric Gastroenterology and Nutrition · 2025

DOI: 10.1002/jpn3.70147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Stefanie Langreen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric and Adolescent Surgery, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Budesonide, Portoenterostomy, Hepatic, Glucocorticoids, Biliary Atresia. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Intravenous or oral steroid administration in patients with biliary atresia (BA) after Kasai hepatoportoenterostomy (HPE) is commonly practiced, however, the benefits remain controversial. Some studies suggest no positive effects while risking steroid associated side effects. Rectal application of glucocorticoids has so far only been assessed by our group with promising short‐term results. We now aim to evaluate the impact of rectal budesonide administration on long‐term native liver survival in patients undergoing HPE for BA.

Methods

We performed a retrospective cohort study and included all patients after HPE who received rectal budesonide (2 mg) for 3 months from 2011 to 2022, compared to a historical control group without any glucocorticoid treatment. Jaundice‐free native liver survival (jfNLS) was assessed at 6 months, 2 years, 5 years, and 10 years post‐Kasai. Serious adverse effects of budesonide were documented.

Results

Our analysis confirmed our previously published improvements in jfNLS at 6 months (53% vs. 39%) and 2 years (45% vs. 22%), while revealing sustained benefits at 5 years (40% vs. 23%) and 10 years (32% vs. 13%). However, these benefits were exclusive to patients with nonsyndromic BA. No serious budesonide‐associated adverse side effects were found.

Conclusions

Our findings support the efficacy of rectal budesonide application in enhancing long‐term outcomes, providing a safe therapeutic approach and improving jfNLS after HPE for BA, without severe adverse effects. Prospective randomized controlled trials are required to further evaluate its potential post‐Kasai benefits and compare it to systemic glucocorticoid therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BudesonidePortoenterostomy, HepaticGlucocorticoidsBiliary AtresiaHumansRetrospective StudiesAdministration, RectalMaleFemaleInfantTreatment OutcomeChild, Preschool

Stichwörter der Autor:innen

biliary atresiacorticoidsliver surgeryliver transplantationpediatric

Substanzen

BudesonideGlucocorticoids

Autor:innen und Institutionen

  • Department of Pediatric and Adolescent Surgery, Hannover Medical School, Hannover, Germany.
  • Department of Kidney, Liver and Metabolic Disease, Division of Pediatric Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany.
  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

ORCID-Profile: Stefanie Langreen

Förderung

  • None

Zitieren

APA

Langreen, S., Pauer, N., Pfister, E. D., Junge, N., Baumann, U., Madadi-Sanjani, O., Petersen, C., Dingemann, J., & Schukfeh, N. (2025). Rectal budesonide: A potential game changer after Kasai hepatoportoenterostomy. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70147

Vancouver

Langreen S, Pauer N, Pfister ED, Junge N, Baumann U, Madadi-Sanjani O, et al. Rectal budesonide: A potential game changer after Kasai hepatoportoenterostomy. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.70147

BibTeX
@article{Langreen2025,
  author = {Langreen, Stefanie and Pauer, Nathalie and Pfister, Eva D and Junge, Norman and Baumann, Ulrich and Madadi-Sanjani, Omid and Petersen, Claus and Dingemann, Jens and Schukfeh, Nagoud},
  title = {Rectal budesonide: A potential game changer after Kasai hepatoportoenterostomy},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2025},
  doi = {10.1002/jpn3.70147}
}
Kostenlos starten →